EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT
With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:
- 35% of collaborative research projects
- 30% of licensing deals
- 15% of equity investment deals
- 20% of services deals
Estimate based on the measurement of 2015 and 2016 delegates’ outcomes
KEY FIGURES:
- 1,300+ delegates
- 800+ organisations
- 35+ countries represented
- 1,000 deals generated in 2017
INSIDE THE EVENT:
- A business convention with pre-qualified one-to-one meetings
- Identification of would-be CEOs
- Conferences and roundtable discussions
- Oral presentations of start-ups , licensing opportunities stemming from academia , service presentations
- An exhibition area
- Informal networking evenings
Please check out the different participants’ lists of the previous editions, as well as the list of this year’s edition >>here<<.
2018 Final programme
2019 Preliminary programme
Please feel free to widely share this document with your colleagues, network, partners…
BE PART OF THE EVENT:
Website: www.biofit-event.com
Twitter: @BIOFIT_EVENT